Dietary Supplement Label Database

Jarro-Dophilus Infant Probiotic Drops

Off market
Photo of the Jarrow Formulas Jarro-Dophilus Infant Probiotic Drops label
Photo of the label, from the NIH's original record · Open full size ↗
Supplement Facts
Serving Size 0.5 mL
Servings Per Container 30
Amount Per Serving% Daily Value
Bifidobacterium longum subsp. infantis M-63Bifidobacterium longum subsp. infantis M-63 Genus: Bifidobacterium Species: longum SubSpecies: infantis Note: (1 billion viable cells (minimum)) (Minimum 1 billion viable cells at time of consumption, under recommended conditions and within best used before date.)†
† Daily Value not established.

Other ingredients: Medium Chain Triglycerides, Tapioca Starch, Calcium Phosphate, Vitamin E, Citric Acid

% Daily Values for: Infants.

Where this label comes from

An original label of the NIH's Dietary Supplement Label Database, entered there on 22 January 2021, shown here as it was entered. The NIH's record

General information

Product name
Jarro-Dophilus Infant Probiotic Drops
Brand
Jarrow Formulas
Barcode (UPC)
7 90011 03014 0
Net contents
0.51 fl. Oz.; 15 mL
Market status
Off market
DSLD ID
243100

Classification

Supplement form
Liquid
Product type
Non-Nutrient/Non-Botanical
Claim types on the label
All Other, Structure/Function
Intended for
Vegan, Vegetarian, Infants/Baby (0 - 1 Year), Gluten Free, Dairy Free

Label statements

Directions: Usage: For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.

Storage: No refrigeration necessary Does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77 degrees F (25 degrees C).

Formula: Contains: Bifidobacterium Longum Subsp. Infantis M-63 Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants. B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species. Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.

FDA Statement of Identity: Probiotic Supplement

Formulation: Does NOT Contain: No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

Formula: Contains: 1 billion live bacteria guaranteed With clinically documented B. infantis M-63

Brand information

Distributed exclusively by: Jarrow Formulas Superior Nutrition and Formulation, Los Angeles, CA

Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.